Taro Pharmaceutical GAAP EPS of $0.73, revenue of $143.26M

May 27, 2022 2:10 AM ETTaro Pharmaceutical Industries Ltd. (TARO)By: Meghavi Singh, SA News Editor
  • Taro Pharmaceutical press release (NYSE:TARO): Q4 GAAP EPS of $0.73.
  • Revenue of $143.26M (-3.4% Y/Y).

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.